LEADER 03852nam 2200865z- 450 001 9910595072103321 005 20231214133114.0 035 $a(CKB)5680000000080807 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/92168 035 $a(EXLCZ)995680000000080807 100 $a20202209d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aVirus Infection in Equine 210 $aBasel$cMDPI Books$d2022 215 $a1 electronic resource (106 p.) 311 $a3-0365-5086-0 311 $a3-0365-5085-2 330 $aThe increased international transportation and trade over the last few decades have increased the risk of the introduction of pathogens into new areas. Global climate change has influenced environmental conditions and the ability of pathogens to survive, and has changed the habitats of certain vectors and hosts. These processes have led to the emergence or re-emergence of various pathogens in different parts of the world, including those affecting horses. This Special Issue features some aspects regarding several well recognized as well as some new and emerging equine viral pathogens, highlighting the need for updated epidemiological data. Such surveillance is crucial for proper decision making by clinicians and by regulatory authorities. Also demonstrated by the recent global emergence of SARS-CoV-2, the development of an effective infrastructure for the rapid and effective detection and control of novel viral pathogens, as well as re-emerging ones, is essential. Horses should play an important role in such surveillance systems, not only for equine pathogens but also as sentinels to other viruses and arboviruses. As was demonstrated in several examples in this Special Issue, it is important to remember, both as clinicians and as researchers, that when facing clinical cases, even when those are common, we should remain alert to the possibility of the intrusion of unknown pathogens and, therefore, should seek a definitive diagnosis. This may allow for the early detection of emerging or re-emerging pathogens. 606 $aMedicine$2bicssc 610 $aequine coronavirus 610 $ahorse 610 $aenteric disease 610 $aECoV 610 $aseroprevalence 610 $aequine 610 $aviruses 610 $aloop-mediated isothermal amplification 610 $ainsulated isothermal polymerase chain reaction 610 $afield-deployable 610 $apoint-of-care testing 610 $aHuculs 610 $aviral status 610 $aimmunological status 610 $aequine viral diseases 610 $aEHV-1 610 $aEHV-4 610 $aELISA 610 $aVNT 610 $aMorocco 610 $aequine parvoviruses 610 $aequine parvovirus hepatitis 610 $aequine parvovirus CSF 610 $aequine copivirus 610 $anasal fluid 610 $ablood 610 $aqPCR 610 $asick equids 610 $ahealthy horses 610 $agammaherpesvirus 610 $ahorses 610 $arespiratory disease 610 $aequine herpesvirus 1, -2, -4, -5 610 $aequine influenza 610 $aquantitative PCR 610 $aequine encephalosis virus 610 $aEEV 610 $aepidemiology 610 $aclinical disease 610 $acontrol 610 $aCulicoides 610 $aSARS-CoV-2 610 $anasal secretions 615 7$aMedicine 700 $aSteinman$b Amir$4edt$01293810 702 $aErster$b Oran$4edt 702 $aSteinman$b Amir$4oth 702 $aErster$b Oran$4oth 906 $aBOOK 912 $a9910595072103321 996 $aVirus Infection in Equine$93041194 997 $aUNINA